{
  "docId": "019de075-0704-766b-8dc2-5164487e52e7",
  "docSlug": "289762853c89269e6344134613f84a84",
  "documentTitle": "OmniAb | Investor Presentation Deck | 39 slides",
  "authorId": "omniab",
  "authorName": "OmniAb",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 39,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 8,
  "notes": "The chart shows a steady upward trend in clinical programs, with the final bar representing Q1 2023.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-0704-766b-8dc2-5164487e52e7/9",
  "deckHref": "/decks/019de075-0704-766b-8dc2-5164487e52e7",
  "deckJsonHref": "/decks/019de075-0704-766b-8dc2-5164487e52e7.json",
  "deckAnchorHref": "/decks/019de075-0704-766b-8dc2-5164487e52e7#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.3,
        "x": 0.65,
        "y": 0.12
      },
      "kind": "chart",
      "text": "Number of Active Clinical Programs and Approved Products",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c14b7f2-e9e8-4827-a54a-96a9065c4515",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.6,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "list",
      "text": "New program entered the clinic in Q1 2023\nSGN-BB228 (Seagen): Anti-CD228 x 4-1BB Anticalin\nBased on dialog with partners, we see potential for approximately 3-5 new entries into clinical development for novel OmniAb-derived antibodies in 2023\nPartner progression also showing the flexibility of our platform, with an increasing number of formats and modalities in clinical or preclinical development",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "68c0c2e1-4a69-463d-8707-0d811849a8fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.55,
        "x": 0.04,
        "y": 0.12
      },
      "kind": "subtitle",
      "text": "ACTIVE CLINICAL PROGRAMS AND APPROVED PRODUCTS",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "717de9d2-d923-4309-b182-3b82209955c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.4,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "Performance Indicators",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e362923d-fe28-437d-9e97-4a21f2064da9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "06071590-db3f-48fb-a0b1-24c9482038ef",
      "evidence": "The slide presents information in a list format.",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 6,
      "beatId": "3c747586-5f51-405c-b39c-0f663acb5a84",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Interest",
      "beatSlug": "aida-interest",
      "evidence": "The deck presents the company's solution, technology offering, and traction to generate interest.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "c9464b73-5d72-4cd7-a643-34a139bcb87a",
      "evidence": "The deck presents the need for discovery technology and the limitations of current solutions.",
      "position": 0,
      "objective": "What are the consequences of not investing in OmniAb's platform?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}